Objective: To identify inhibitors of the essential chromosome partitioning protein ParA that are active against Mycobacterium tuberculosis.
Introduction
The discovery of streptomycin by Selman Waksman in 1943 was believed to herald the end for tuberculosis, 1 a disease that has afflicted mankind for at least 9000 years. 2 However, recent data from the WHO show that there are more than 9 million new cases of the disease each year. 3 In addition, approximately 0.5 million cases are caused by multidrug-resistant (MDR) forms of Mycobacterium tuberculosis, defined as resistant to both isoniazid and rifampicin. 3, 4 The prevalence of MDR tuberculosis is considered a threat to global control programmes as it necessitates an extended and more costly treatment regimen for which the success rate is reduced considerably. 5, 6 In March 2006, the CDC reported the appearance of extensively drug-resistant (XDR) strains of M. tuberculosis, 7 defined as resistant to both isoniazid and rifampicin, one of the fluoroquinolones and one injectable aminoglycoside. 8 According to the WHO, XDR tuberculosis 'leaves patients (including many people living with HIV) virtually untreatable using currently available anti-tuberculosis drugs'. 9 From an initial detection in the USA, South Korea and Latvia in 2006, 58 countries have confirmed at least one case of XDR tuberculosis.
to begin selecting other mycobacterial processes for the discovery of new candidate drugs. 16, 17 Genes essential for basic cellular processes in bacteria represent potential targets for anti-infective therapy as their genetic or chemical inactivation can halt bacterial growth. Cell division, although an essential process in all living organisms, is markedly different in prokaryotes and eukaryotes 18 -20 and has received only modest attention for antibacterial drug discovery to date. 21, 22 Its promise as a source of new drug targets is supported by the recent discovery of zantrins, antagonists of the cell division protein FtsZ, which are active against several clinically important bacterial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumoniae, Shigella dysenteriae, Vibrio cholerae, Escherichia coli and Clostridium perfringens. 21 The discovery of new tuberculosis drugs is dependent on assays that can reliably identify anti-mycobacterial compounds in high throughput. A number of high-throughput screen (HTS) protocols are based on inhibition of a specific purified protein. For example, White et al. 23 used the rate of ATP utilization by pantothenate synthetase (PS) to identify inhibitors of M. tuberculosis PS, an essential enzyme for coenzyme A and acyl carrier protein biosynthesis. Bhat et al. 24 used the incorporation of a fluorescent analogue of uridine monophosphate (UMP) into nascent RNA to perform HTS for inhibitors of RNA polymerase of E. coli and validated hits against the RNA polymerases of Mycobacterium smegmatis and Mycobacterium bovis. 24 While these assays can detect inhibitors of specific enzymes, they are unable to eliminate compounds that have poor permeability with respect to entry into the mycobacterial cell. On the other hand, whole-cell assays address the issue of compound permeability; however, they do not provide information on the cellular target of the inhibitors detected.
To overcome the above challenges, we set up a whole-cell assay to enable detection of inhibitors of a protein that is required in the mycobacterial cell division process, ParA. 25 The assay consisted of a differential sensitivity screen for compounds that act synergistically with parA antisense expression. Using this approach, compounds that enhanced the inhibitory effect of parA antisense expression of M. smegmatis were identified from chemical libraries. These compounds were validated using purified ParA protein and tested for activity against M. tuberculosis.
Methods
Bacterial strains and growth conditions E. coli DH5a and E. coli BL21 (DE3) were cultured in Luria-Bertani broth (LB) and on Luria-Bertani agar (LA). M. smegmatis mc 2 155 was cultured in LB supplemented with 0.1% Tween 80 (LBT) and on LA. M. bovis BCG and M. tuberculosis H37Ra were cultured in Middlebrook 7H9 broth supplemented with 10% (v/v) OADC (0.06% oleic acid/5% BSA/2% dextrose/0.85% NaCl), 0.5% (v/v) glycerol and 0.1% (v/v) Tween 80. M. tuberculosis H37Rv and CDC1551 were cultured in Middlebrook 7H9 broth supplemented with 10% (v/v) OADC, 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80. Nutrient-limitation assays of M. smegmatis were conducted using Hartman-de Bonts (HdeB) minimal medium as previously described. 26, 27 All strains were cultured at 378C.
Construction of a conditional antisense expression vector
M. smegmatis genomic DNA was extracted as previously described 28 ′ -CTAGGATATCCTACTGCTGGCGCGGCGGCG-3 ′ ) for MSMEG_6939 antisense. MSMEG_6939_F and MSMEG_6938_R were used to generate the combined MSMEG_6938 +6939 antisense fragment. The endonuclease restriction sites in the primers are underlined. For the analysis of PCR-amplified DNA fragments, the TA cloning vector pCR2.1 (Invitrogen) was used and recombinants were selected using blue/white colony screening on LA supplemented with 200 mg/L ampicillin, 50 mg/L kanamycin, 100 mg/L IPTG and 40 mg/L 5-bromo-4-chloro-3-indolylb-D-galactopyranoside (Xgal). Pure colonies were cultured in LB supplemented with 200 mg/L ampicillin and 50 mg/L kanamycin.
A modified version of the mycobacterial expression vector pMind containing the tetR gene and tetO operator from Corynebacterium glutamicum was used to induce antisense gene expression as previously described.
29 pHS201 30 was used as a template for PCR amplification of the green fluorescent protein (gfp) gene using primers GFP_RBS_F (5 ′ -CTAGACTAGTTTTAAGAAGGAGATATACATATGAGTAAAGGAGGA-3 ′ ) and GFP_R (5 ′ -CTAGACTAGTTTATTATTTGTATAGTTCATCCATGCC-3 ′ ). The gfp gene was inserted into the SpeI site of the pMind vector downstream of the tetO operator, generating pMindGFP ( Figure 1 ). The orientation of fragments in pMind was determined by PCR using a primer complementary to the tetO operator, TetRO-F11 (5 ′ -CTTCCGGTGGTGAGTCATAG-3 ′ ), and the forward and reverse primers were used to generate the fragment. In addition, a primer complementary to the hygromycin resistance gene, HygR11 (5 ′ -AAGTAACAGGGATTCTTGTGTCAC-3 ′ ), was used together with the forward and reverse primers. pMindGFP containing the antisense fragments of MSMEG_2357, MSMEG_6938, MSMEG_6939 and MSMEG_6938+6939 was electroporated into M. smegmatis using a Bio-Rad Gene Pulser II instrument. Transformants were incubated at 378C overnight and selected on LA supplemented with 50 mg/L kanamycin and 50 mg/L hygromycin.
Bacterial growth assays
Growth assays of M. smegmatis/pMindGFP, M. smegmatis/pMind2357, M. smegmatis/pMind6938GFP and M. smegmatis/pMind6939GFP were conducted in nutrient-rich (LBT) and nutrient-limited (HdeB) media. For nutrient-limitation assays, starter cultures were grown overnight in HdeB media containing 0.2% (v/v) glycerol. For the carbon-limitation assays, the starter cultures were subcultured into HdeB medium supplemented with 0.08% (v/v) glycerol. For the nitrogen-limitation assays, glycerol was present at 0.2% (v/v) and the (NH 4 ) 2 SO 4 concentration was reduced 100-fold to 0.15 mM. Each growth assay was performed in quintuplicate in 96-well plates in a total volume of 100 mL with an initial optical density at 590 nm (OD 590 ) of 0.01 (equivalent to an OD 600 of approximately 0.05 in a 10 mm path length cuvette). For induction of antisense, 0.02 mg/L tetracycline was added. The cultures were monitored for OD 590 and fluorescence using a Wallac Envision plate reader (Perkin-Elmer). Samples of the cultures were taken at different timepoints, serially diluted and plated onto LA medium to determine the cfu of the cultures.
Differential antisense sensitivity screening of chemical libraries
The M. smegmatis/pMind6939GFP strain was screened against two compound libraries: LOPAC (Sigma-Aldrich) and Spectrum Collection Nisa et al.
(Microsource Discovery Systems) in nutrient-rich and carbon-and nitrogen-limited growth conditions as previously described. 31 Tetracycline was present at a concentration of 0.02 mg/L for induction of antisense expression. Starter cultures were subcultured in 96-well plates to a starting OD 590 of 0.07 and library compounds were applied at a final concentration of 20 mM in a volume of 100 mL as previously described. 31 Plates were sealed with plate seals, wrapped in cling film and incubated at 378C until after the cultures reached stationary phase: 72 h for carbon-and nitrogen-limited conditions and 144 h for nutrient-rich conditions. All screens were performed three times. Parallel screens were performed with a reference strain expressing antisense of a putative essential gene, MSMEG_2357, which is not involved in cell division. M. smegmatis/ pMind2357 strain displayed growth patterns that were similar to M. smegmatis/pMind6939GFP (data not shown). Compounds that inhibited both strains in the library screen were excluded. Compounds exhibiting greater than 40% growth inhibition of the M. smegmatis/pMind6939GFP strain with respect to the reference strain in all three screens were selected for further characterization. Z-factors were calculated for each screen to determine the fidelity of the assays.
Overexpression of ParA and ParB from M. tuberculosis M. tuberculosis genomic DNA was extracted as previously described 28 and used as a template for PCR amplification of the Rv3917c (parB) and Rv3918c (parA) genes. PCR experiments were carried out as per the manufacturer's instructions with the following primers: ParB_F (5 ′ -CTAG AGATCTATGACCCAGCCGTCACGCAG-3 ′ ) and ParB_R (5 ′ -CTAGAAGCTT TTACAGAGCGTCCCTGTGCA-3 ′ ) for Rv3917c; and ParA_F (5 ′ -CTAGAGATCT GTGAGTGCTCCGTGGGGCCC-3 ′ ) and ParA_R (5 ′ -CTAGAAGCTTTCATGGTCG TCCCTTCGCGG-3 ′ ) for Rv3918c. The endonuclease restriction sites in the primers are underlined. Analysis of PCR-amplified DNA fragments was carried out using the TA cloning vector pCR2.1, as described above. The M. tuberculosis genes were subcloned from the pCR2.1 vectors into the BamHI and HindIII sites of the pET-28a(+) plasmid (Novagen) to generate pET-28a(+)_ParA and pET-28a(+)_ParB. These vectors were transformed into E. coli BL21 (DE3) and selected for on LA plates supplemented with 50 mg/L kanamycin. E. coli BL21 (DE3)/pET-28a(+)_ ParA and E. coli BL21 (DE3)/pET-28a(+)_ParB were cultured overnight in LB supplemented with 50 mg/L kanamycin. Protein expression was induced by subculturing 1 mL of the overnight cultures into 500 mL of ZYP-5052 autoinduction medium. 32 The cultures were grown overnight and cells were harvested using centrifugation. Protein purification was carried out using a HisBind Purification kit (Novagen) except the cells were lysed by sonication in 30 mL binding buffer (Novagen). All buffers used for the purification of ParA were supplemented with 10% glycerol. Dialysed ParA protein was stored in 50% glycerol at 2208C.
In silico structural analyses of interactions between inhibitors and ParA
A homology model of M. tuberculosis ParA (NCBI Reference Sequence: NP_218434.2) was generated using Modeller 9v7. 33 The sequence of ParA was used as a BLAST search query of the Protein Data Bank, and this resulted in multiple hits with the pdb2BEJ giving the lowest E-value ParA as an anti-tubercular drug target 2349 JAC [E-value, 4.55822e248; identity, 118/255 (46%)]. A sequence alignment was carried out via the T-coffee (v7.38) webserver (http://www.igs. cnrs-mrs.fr/Tcoffee/tcoffee_cgi/index.cgi). Five models (residues G82-P341; magnesium ion and four coordinated water molecules) were generated from the alignment and the model with the lowest objective function was chosen for docking studies. Low-energy ligand structures were either generated using OMEGA2 and protonated using filter (Openeye software www.eyesopen.com) or were generated in SYBYL-X using the sketcher module (SYBYL-X, Tripos International, St Louis, MO, USA). These ligands were energy-minimized to a low-energy starting conformation using the Tripos forcefield. Flexible ligand docking was carried out with Gold 4.1 34 using the ChemScore scoring function. Threonine-100 was designated as the centre of the ligand binding site with a radius of up to 15 Å . The metal ion was designated as octahedral and all other parameters were default. Graphics were generated using the PyMOL Molecular Graphics System, Version 1.2r3pre.
Development of a ParA ATPase assay and validation of ParA inhibitors
An initial biochemical assay was set up with 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 10 mM MgCl 2 , 1 mM dithiothreitol (DTT), 0.1 mg/mL BSA, 1 mM ATP, 3 mg ParA, 3 mg ParB and 1 mg parS DNA in a total volume of 100 mL. The parS region was amplified from M. tuberculosis with primers ParS_H37Rv_F
The reaction was incubated for 1 h at 378C and quantification of inorganic phosphate (P i ) release was used to determine ATPase activity as previously described. 35 Briefly, 20 mL of Reagent A [4.2% (w/v) ammonium molybdate in 4 M sulphuric acid] was added to the ATPase assay followed by 20 mL of Reagent B [0.045% (w/v) brilliant green in H 2 O]. The assay reagents were mixed and the reaction was read after 2 -5 min at 650 nm. The effects of temperature, presence of divalent cations and presence of ParB and parS were also tested in this assay. For validation of the activity of the inhibitors towards ParA, the standard ATPase reactions contained 50 mM Tris-HCl (pH 7.5), 50 mM KCl, 1 mM MgCl 2 , 1 mM DTT, 100 mg/L BSA, 50 mM ATP and 1 mg of ParA in a total volume of 100 mL. The reaction mixtures were incubated at 378C for 3 h and ATPase activity was measured as described above.
DAPI staining of M. smegmatis cells
The effects of the validated ParA inhibitors on M. smegmatis/pMindGFP and M. smegmatis/pMind6939GFP cells were determined under nitrogenlimitation conditions in the presence of 0.02 mg/L tetracycline. Cell morphology and DNA localization were determined by fluorescence microscopy following staining of the cells with 4 ′ ,6-diamidino-2-phenylindole (DAPI; Molecular Probes) as per the manufacturer's instructions. Cell lengths were derived from the mean of 100 cells for each culture+standard error.
Effect of ParA inhibitors on M. smegmatis, M. bovis BCG and M. tuberculosis cells
The effects of validated ParA inhibitors were tested on M. smegmatis, M. bovis BCG and M. tuberculosis H37Ra. Cells were cultured to midlogarithmic phase and diluted to a starting OD 590 of 0.01. Sterile deionized water (200 mL) was added to each well on the perimeter of the plate to minimize evaporation of the growth medium during the assay. Growth medium (50 mL) was added to the remaining wells. Starting at 1 mM, 2-fold serial dilutions were performed for the experimental compounds and control antibiotics. Cell culture (50 mL) was added to each inner well, except the medium control wells. The plates were sealed, wrapped in cling film and incubated at 378C with 200 rpm shaking for 4 days for M. smegmatis and 14 days for the slow-growing mycobacteria.
At the end of each assay, the OD 590 of the cultures was measured and the data were analysed with SigmaPlot 11 (Systat) using four-parameter logistic standard curve analysis. The MIC 90 values were determined with respect to controls. The effects of the ParA inhibitors were also validated in virulent M. tuberculosis strains H37Rv and CDC1551. Briefly, the laboratory strain H37Rv and the clinical isolate CDC1551 were grown to mid-log phase and cultures were diluted to an OD 600 of 0.001 in 7H9 without Tween 80. MICs were determined by the microplate Alamar Blue assay (MABA). Diluted culture (100 mL) containing approximately 10 4 cfu was added to each well containing either serially diluted inhibitors or isoniazid control. Plates were incubated at 378C for 7 days and 35 mL of Alamar Blue/Tween 80 (2:1.5, v/v) was added to each well and the wells were incubated for 16 h. Plates were read at 544ex/590em with the Optima microplate reader (BMG) and MIC 90 values were determined.
Results

Introduction of antisense expression vectors into M. smegmatis
The antisense expression vectors were introduced into M. smegmatis by electroporation. M. smegmatis containing pMind6938GFP or pMind6939GFP formed 1-3 mm colonies on solid medium after 72 h (Figure 2a ). In contrast, M. smegmatis containing the pMind6938 + 6939GFP vector took approximately 2 weeks to form 1 -3 mm colonies on solid medium and was not used in further studies. The M. smegmatis/pMind6938GFP and M. smegmatis/pMind6939GFP strains were analysed for GFP expression with and without tetracycline. The observed GFP expression in the absence of tetracycline (Figure 2b) indicates that the tetracycline-inducible system on pMindGFP is not tightly regulated. A similar observation has been reported previously for a tetracycline-inducible system used in Staphylococcus aureus.
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The basal expression may account for the severe growth retardation that was observed for M. smegmatis containing the antisense fragments for both MSMEG_6938 and MSMEG_6939 (Figure 2a) . However, addition of tetracycline resulted in a significantly higher level of GFP fluorescence (Figure 2b) , which was indicative of induction of expression from the tetO operator on pMindGFP.
Effect of antisense expression on M. smegmatis
The bacterial growth assays were carried out over a period of 300 h and the OD 590 values of the cultures were measured at regular intervals. All cfu data were compared with data for the M. smegmatis/pMindGFP control strain. Under nutrient-rich conditions, induction of antisense expression did not significantly affect the optical density of the cells (Figure 3a) . However, there was an 300-fold decrease in the cfu at the late stationary phase in M. smegmatis/pMind6939GFP with respect to the control strain M. smegmatis/pMindGFP (Figure 3b ). Under the carbon-limitation conditions, induction of MSMEG_6939 antisense resulted in M. smegmatis/pMind6939GFP cultures taking longer to enter stationary phase and this was accompanied by a 14-fold decrease in cfu in M. smegmatis/pMind6939GFP cultures (Figure 3c and d) . Under nitrogen-starvation conditions, induction of antisense significantly lowered the growth rate and cfu count of the M. smegmatis/pMind6939GFP strain (Figure 3e and f) . Expression of MSMEG_6939 antisense under nitrogen starvation conditions also affected cell morphology.
Nisa et al.
The parA antisense-expressing cells had multiple chromosomal foci along the length of the cells (see Figure 6b ) compared with control cells (see Figure 6a) . Induction of parB antisense expression did not significantly affect the growth or cfu of the M. smegmatis/pMind6938GFP strain under any of the culture conditions tested. In vitro characterization of ParA from M. tuberculosis
The bacterial ParA protein belongs to a family of P-loop (Walker A box) ATPases. 37 An analysis of the sequence of the ParA protein of M. tuberculosis encoded by Rv3918c using the Conserved Domain Database (http://www.ncbi.nlm.nih.gov/Structure/cdd/ cdd.shtml) predicts the presence of a P-loop ATPase domain. To test ParA from M. tuberculosis for ATPase activity, the protein was expressed in E. coli and purified. It was found to hydrolyse ATP in the absence of ParB and parS (Figure 4a) (Table 1) . This activity was inhibited by the P-loop ATPase inhibitor metavanadate by approximately 50% at concentrations of 100 mM and higher (Figure 4c) .
Inhibition of the ATPase activity of ParA
The optimized ATPase assay was subsequently used to validate seven compounds from the chemical library screens that inhibited the growth of and induced an elongated cell phenotype in the parA antisense-expressing strain. Three of these compounds, methiothepin mesylate, (+)-octoclothepin maleate and phenoxybenzamine hydrochloride, showed inhibition in the in vitro ParA ATPase assay. Increasing concentrations of phenoxybenzamine progressively decreased the activity of ParA ATPase up to 50% at a concentration of 250 mM (Figure 4d ). Concentrations of phenoxybenzamine greater than 250 mM resulted in precipitation of the compound, which interfered with colour development in the Malachite Green assay. Phenoxybenzamine appears to be a mixed inhibitor of ParA, suggesting that it can bind to both the enzyme and the enzyme-substrate complex ( Table 1) . Addition of octoclothepin resulted in an 20% decrease in the ParA ATPase activity at a concentration of 25 mM and higher (Figure 4d ). Octoclothepin appears to be a competitive inhibitor of ParA whereby the substrate binding affinity of ParA decreases in the presence of the inhibitors (Table 1) . Methiothepin, which is very similar in structure to octoclothepin, yielded nearly identical ParA inhibition results to octoclothepin (data not shown). The standard tuberculosis drugs ethambutol 
Predicted interactions between inhibitors and the ATPase domain of ParA
A homology model of M. tuberculosis ParA was generated based on the template structure of Soj from Thermus thermophilus. 
Inhibition of mycobacterial growth by ParA inhibitors
The effect of the ParA inhibitors on the cell morphology of M. smegmatis was tested. Induction of parA antisense in M. smegmatis resulted in a minor but statistically significant increase in cell length (5.08+1.45 to 6.8+1.3 mm). Cells expressing parA antisense also appeared to exhibit a higher number of chromosomal foci with respect to control M. smegmatis/pMindGFP cells (Figure 6a and b) . Incubation of the parA antisense-expressing strain in the presence of 20 mM phenoxybenzamine or octoclothepin resulted in a large increase in cell length to 11.36+2.6 and 14.78+3.18 mm, respectively, and an observable increase in chromosomal foci number (Figure 6c and d) . On the other hand, the compounds at 20 mM did not induce an elongated cell phenotype in the absence of parA antisense (data not shown). In terms of an effect on growth, under nutrient-rich conditions phenoxybenzamine had no detectable effect on the growth of M. smegmatis up to a concentration of 1000 mM (340 mg/L). In contrast, octoclothepin gave an MIC 90 of 61.16 mM (28 mg/L) ( Table 2 ). M. smegmatis Table 2 ). The effect of the ParA inhibitors on the growth of other species of mycobacteria was also tested grown under nutrient-rich conditions. Again, phenoxybenzamine did not exhibit detectable activity under these conditions. Octoclothepin, on the other hand, was active against M. bovis BCG and avirulent and virulent strains of M. tuberculosis, with the lowest MIC 90 value obtained for strain CDC1551, 17.4 mM or 8 mg/L ( Table 2 ).
Discussion
The spread of antibiotic resistance in human pathogens has necessitated the identification of new cellular targets and their cognate inhibitors for the development of alternative antimicrobial drugs. 39, 40 One approach used in the identification of drug targets is the determination of a minimal gene set for a pathogen. A minimal gene set consists of genes that are essential and sufficient for sustaining a living organism under favourable ParA as an anti-tubercular drug target 2355 JAC conditions with all requisite nutrients provided and in the absence of environmental stress. 41 Chemical blocking of an essential gene product may provide an effective way to inhibit growth of a pathogen. In earlier work by Sassetti et al.,
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M. tuberculosis H37Rv was mutated by high-density transposon mutagenesis and the loci containing transposon insertions were established. Transposon insertions were not obtained for 614 of the 3995 known M. tuberculosis genes, 17 which raised the possibility that many of these genes are essential for mycobacterial growth.
In this work, we selected the chromosomal partitioning par system as a potential drug target based on the transposon mutagenesis findings that parA (Rv3918c) and parB (Rv3917c) may be indispensable in M. tuberculosis. 25 Furthermore, orthologues of parA are also essential in a range of other bacterial species from our analysis of the Database of Essential Genes (http://tubic.tju.edu.cn/deg/). The role of the par system has been best characterized for plasmid partitioning, whereby DNA segregation is mediated by the plasmid-encoded proteins ParA and ParB and a cis-acting centromere-like partition site, pars. 19, 42 Plasmid partitioning is an active process that requires the separation and maintenance of replicated DNA at subcellular locations. 43 Energy is derived from the ATPase activity of ParA, which is recruited to the partition nucleoprotein complex (ParB -parS) via its interaction with ParB. 44 ParB binds the centromere-like parS sites and membrane-bound proteins. 45, 46 This process aligns the newly replicated plasmid towards the cell poles to ensure equipartitioning during division. Chromosomally encoded orthologues of the par system are understood to function in a similar manner to the plasmid par system and participate in the segregation of the newly formed daughter chromosomes during cell division. 19 In this study, antisense expression of parA and parB was used to examine their essentiality in M. smegmatis. Antisense gene expression has been used previously to repress essential gene expression in a number of bacterial species, including M. smegmatis, 29, 47, 48 M. tuberculosis, 49 Staphylococcus aureus 50, 51 and Streptococcus mutans. 52 To detect induction of the gene antisense, a gfp reporter gene was cloned downstream of the antisense fragment. Only the expression of parA antisense was found to hinder the growth of M. smegmatis, indicating that ParA, but not ParB, may be essential in M. smegmatis (Figure 3) . Other researchers have shown that parB can be inactivated in M. smegmatis, 53 indicating that parB is not essential in this species. Expression of parA antisense was then used in the identification of inhibitors of mycobacterial growth from chemical libraries. An antisense differential sensitivity whole-cell approach similar to what has previously been applied to the identification of specific inhibitors of FabI 36 and FabF 54 -57 in Staphylococcus aureus was used. Screens were carried out under three different growth conditions. It has been established previously that mycobacteria reduce transcription of genes involved in processes such as energy metabolism, translation and cell division upon nutrient starvation. 58 This global shift in gene expression can affect the susceptibility of mycobacterial cells to antibacterial agents. Indeed, we have previously shown in our laboratory that nutrient limitation significantly changes the activity profile of a chemical library and can cause substantial shifts in the MICs of some compounds. 31 Furthermore, it has been demonstrated that transcription of parA is down-regulated upon nutrient starvation in M. tuberculosis. 58 This effect on parA expression would be expected to modulate the sensitivity of mycobacteria to compounds that target ParA, and hence the screens were performed under nutrient-limited as well as nutrient-rich conditions.
Parallel screens with a reference strain expressing antisense RNA of a putative essential gene, not involved in the cell division process, were performed. Compounds that inhibited growth of both strains were excluded, whereas 44 distinct compounds displayed differential activity towards the parA antisense strain. Of these, seven compounds also caused cell elongation, indicating a possible effect on cell division or chromosomal partitioning. These latter compounds were selected for validation against the purified ParA protein from M. tuberculosis. Three compounds, phenoxybenzamine, octoclothepin and methiothepin, were found to inhibit the ATPase activity of M. tuberculosis ParA in vitro (Figure 4 ). Their interaction with ParA was supported by in silico analysis, which indicated that these compounds bind within the ATPase site of ParA ( Figure 5 ).
The effects of phenoxybenzamine and octoclothepin on cell morphology and growth were examined in M. smegmatis. In the presence of parA antisense, both compounds resulted in a significantly elongated cell phenotype and an increase in the amount of nucleation visible ( Figure 6 ). A change in cell morphology was not evident when the compounds were administered in the absence of parA antisense; however, the compounds inhibited the growth of M. smegmatis (Table 2) .
Under the three culture conditions tested, octoclothepin was the more active of the two compounds. Phenoxybenzamine exhibited no inhibitory activity under nutrient-rich conditions, but was active against M. smegmatis under nitrogen limitation ( Table 2) . The compounds were also tested against slow-growing mycobacteria. Again, phenoxybenzamine was inactive against all strains when tested under nutrient-rich conditions. We are currently developing a nutrient-limitation model for M. bovis BCG and M. tuberculosis to examine whether nutrient deprivation alters the activity of phenoxybenzamine in these species as was seen in M. smegmatis. On the other hand, octoclothepin was active against all of the slow-growing mycobacterial strains tested (Table 2) . Although octoclothepin exhibited lower inhibitory activity towards purified ParA in vitro with respect to phenoxybenzamine, its higher activity against mycobacterial cells indicates that it may target other ATPases in the mycobacterial cell in addition to ParA.
Octoclothepin is an analogue of the piperazine derivative clozapine, which is used in the treatment of schizophrenia 59 under a variety of brand names including Denzapine and Zaponex. Clozapine is an agonist of a number of dopamine receptors such as the D 4 receptor, 60 but also acts as an antagonist of adrenergic and histaminergic receptors. 61 Previous in silico analyses of octoclothepin resulted in it being predicted to be nonantibacterial; 62, 63 however, this study clearly demonstrates that it has anti-mycobacterial properties. Importantly, octoclothepin is active against virulent M. tuberculosis (Table 2 ) and its measured level of toxicity in mice-an oral 50% lethal dose (LD 50 ) of 78 mg/kg-compares well with that of isoniazid, 133 mg/kg (ChemIDplus Advanced). Therefore, this compound deserves further attention as a possible anti-tubercular agent. Methiothepin has been detected in a high-throughput growth inhibition assay with M. tuberculosis H37Rv performed by the Southern Research Institute (data available at http://pubchem.ncbi.nlm.nih.gov/); Nisa et al.
however, an antibacterial cellular target for this compound has not been described to date.
Phenoxybenzamine, marketed as Dibenzyline w by Wellspring Pharmaceutical Corporation, is a haloalkylamine used in the treatment of hypertension. 64 It is also used in the treatment of benign prostatic hyperplasia. 65 It acts by covalently binding to and blocking a1 and a2 adrenergic receptors in vascular smooth muscle, resulting in systemic vasodilation. Phenoxybenzamine administered orally is well tolerated in rats (LD 50 of 2500 mg/kg), mice (LD 50 of 1536 mg/kg) and guinea pigs (LD 50 of 500 mg/kg). 66 An earlier study found that pre-treatment of mice with phenoxybenzamine reduced pneumococcal and staphylococcal sepsis mortalities through decreased vasoconstriction, 67 but we have been unable to find reports of direct antibacterial activity for phenoxybenzamine.
In summary, we have demonstrated that screening using differential antisense sensitivity can identify specific inhibitors of mycobacterial cellular targets from a large number of library compounds. Using this approach we have identified inhibitors of the ParA ATPase, an essential chromosome partitioning protein, of M. tuberculosis. These compounds represent the first reported inhibitors identified for this protein in mycobacteria and may provide a basis for the further development of ParA as a cell division target for anti-tubercular drugs. One compound in particular, octoclothepin, inhibits the growth of virulent M. tuberculosis and will be the subject of future structureactivity studies.
